Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book

IJ Pharmaceutical Research

homeHome
play_arrowCurrent Issueformat_list_bulletedAll Issuesformat_indent_increaseIn Presscheck_boxAccepted Manuscripts
searchSearchqr_codeInstructions
bookmarkJournal InformationgroupsEditors & BoardsshareIndexing and Listing Sourceswaterfall_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Malpractice Statementassignment_indReviewer and AE Registration FormemailSupportphoneContact Us
menuAPC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)

1. Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus

- Kabir M.T. , et al.

2. Effect of bedtime melatonin administration in patients with type 2 diabetes: A triple-blind, placebo-controlled, randomized trial

- Farrokhian A. , et al.

3. Comparative study of the effects of chamomile (Matricaria chamomilla l.) and cabergoline on idiopathic hyperprolactinemia: A pilot randomized controlled trial

- Kabiri M. , et al.

4. Current views on dopaminergic drugs affecting glucose homeostasis

- Hassanabad M.F. , et al.

5. Different cabergoline effect on metabolic and anthropometric parameters in female prolactinoma patients versus idiopathic hyperprolactinemia patients

- Aboelnaga M.M. , et al.

6. Effects of parenteral vitamin D on the biomarkers of the endothelial function in patients with type 2 diabetes and ischemic heart disease: A randomized clinical trial

- Talasaz A.H. , et al.

7. Effects of cabergoline on blood glucose levels in type 2 diabetic patients: A double-blind controlled clinical trial

- Bahar A. , et al.